Use of PEDF-derived polypeptides for promoting stem cells proliferation and wound healing
Disclosed herein is a synthetic peptide, which has an amino acid sequence that has 20-39 amino acid residues. The synthetic peptide has at least 80% amino acid sequence identity to SEQ ID NO: 1, and includes at least 20 consecutive residues that has at least 90% amino acid sequence identity to residues 11-30 of SEQ ID NO: 1. Also disclosed herein are compositions containing the synthetic peptide and applications thereof. According to various embodiments of the present disclosure, the synthetic peptide is useful in promoting stem cells proliferation or wound healing.
1. A method for promoting healing of a corneal or an epithelial wound in a subject, comprising administering a therapeutically effective amount of a synthetic peptide to the subject to promote stem cells associated with the corneal or epithelial wound of the subject to proliferate, wherein
the stem cells are limbal epithelial stem cells or hair follicle stem cells,
the amino acid sequence of the synthetic peptide consists of 20-39 amino acid residues and has at least 80% amino acid sequence identity to SEQ ID NO: 1, wherein at least 20consecutive residues of the synthetic peptide has 100% amino acid sequence identity to residues 11-30 of SEQ ID NO: 1, and
the percentage in healing of the corneal wound is increased by up to 90% after 48 hours or the percentage in healing of the epithelial wound is increased by up to 50% after 7 days as compared to corneal wound or epithelial wound healing with full-length human Pigment epithelium-derived factor (PEDF).
2. The method of claim 1 , wherein the amino acid sequence is selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, and SEQ ID NO: 5.
3. The method of claim 1 , wherein the synthetic peptide is administered to the subject via topical administration, subconjunctival injection, subcutaneous injection, or intradermal injection.